MedTrace Logo

AngioDefender Versus Brachial Artery Ultrasound Imaging

NCT02468336 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 171

Last updated 2018-02-01

No results posted yet for this study

Summary

The objective of this study is to demonstrate that the investigational device, AngioDefender, is comparable to the established procedure referred to as 'brachial artery ultrasound imaging' in their abilities to quantify flow-mediated vasodilation of the brachial artery.

Conditions

Interventions

DEVICE

AngioDefender

DEVICE

Ultrasound

Sponsors & Collaborators

  • Everist Genomics, Inc

    lead INDUSTRY

Principal Investigators

  • Peter F Lenehan, MD PhD · Everist Health

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2017-02-15
Completion
2017-02-15

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02468336 on ClinicalTrials.gov